1. Home
  2. GBIO vs TLYS Comparison

GBIO vs TLYS Comparison

Compare GBIO & TLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • TLYS
  • Stock Information
  • Founded
  • GBIO 2016
  • TLYS 1982
  • Country
  • GBIO United States
  • TLYS United States
  • Employees
  • GBIO N/A
  • TLYS N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • TLYS Clothing/Shoe/Accessory Stores
  • Sector
  • GBIO Health Care
  • TLYS Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • TLYS Nasdaq
  • Market Cap
  • GBIO 41.2M
  • TLYS 44.0M
  • IPO Year
  • GBIO 2020
  • TLYS 2012
  • Fundamental
  • Price
  • GBIO $5.19
  • TLYS $1.40
  • Analyst Decision
  • GBIO Buy
  • TLYS Hold
  • Analyst Count
  • GBIO 4
  • TLYS 2
  • Target Price
  • GBIO $10.67
  • TLYS $2.25
  • AVG Volume (30 Days)
  • GBIO 68.4K
  • TLYS 87.7K
  • Earning Date
  • GBIO 11-05-2025
  • TLYS 12-04-2025
  • Dividend Yield
  • GBIO N/A
  • TLYS N/A
  • EPS Growth
  • GBIO N/A
  • TLYS N/A
  • EPS
  • GBIO N/A
  • TLYS N/A
  • Revenue
  • GBIO $21,230,000.00
  • TLYS $549,597,000.00
  • Revenue This Year
  • GBIO N/A
  • TLYS N/A
  • Revenue Next Year
  • GBIO N/A
  • TLYS $1.18
  • P/E Ratio
  • GBIO N/A
  • TLYS N/A
  • Revenue Growth
  • GBIO 61.15
  • TLYS N/A
  • 52 Week Low
  • GBIO $3.00
  • TLYS $0.57
  • 52 Week High
  • GBIO $25.70
  • TLYS $4.77
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 33.89
  • TLYS 33.98
  • Support Level
  • GBIO $5.10
  • TLYS $1.66
  • Resistance Level
  • GBIO $6.47
  • TLYS $1.55
  • Average True Range (ATR)
  • GBIO 0.24
  • TLYS 0.09
  • MACD
  • GBIO -0.12
  • TLYS -0.02
  • Stochastic Oscillator
  • GBIO 11.68
  • TLYS 0.63

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

Share on Social Networks: